Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,307 | -8,782 | -5,915 | -4,149 | -14,385 |
| Depreciation Amortization | -32 | -20 | -6 | -2 | -29 |
| Other Working Capital | -178 | -456 | -641 | 899 | -302 |
| Other Operating Activity | -3,710 | -2,476 | -2,050 | -297 | -2,636 |
| Operating Cash Flow | $-13,227 | $-11,734 | $-8,612 | $-3,550 | $-17,352 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,493 | -187 | 1,718 | -762 | 9,617 |
| PPE Investments | -9 | -8 | -8 | -5 | -62 |
| Investing Cash Flow | $4,484 | $-196 | $1,711 | $-766 | $9,554 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,122 | 10,122 | 4,580 | 4,580 | 8,171 |
| Financing Cash Flow | $10,122 | $10,122 | $4,580 | $4,580 | $8,171 |
| Beginning Cash Position | 10,199 | 10,199 | 10,199 | 10,199 | 9,826 |
| End Cash Position | 11,579 | 8,392 | 7,878 | 10,464 | 10,199 |
| Net Cash Flow | $1,379 | $-1,807 | $-2,321 | $264 | $373 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,227 | -11,734 | -8,612 | -3,550 | -17,352 |
| Capital Expenditure | -9 | -8 | -8 | -5 | -62 |
| Free Cash Flow | -13,236 | -11,742 | -8,620 | -3,554 | -17,414 |